Donor immune cells join fight against advanced throat cancer
NCT ID NCT07247201
Summary
This trial is testing whether adding donor immune cells called Natural Killer (NK) cells to standard chemotherapy and radiation can reduce cancer recurrence in patients with advanced nasopharyngeal cancer. The study will first find the safest dose of these donor cells, then test that dose in more patients to see if it lowers detectable cancer markers after treatment. Researchers hope this combination approach will help control the disease better than standard treatment alone.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MINIMAL RESIDUAL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.